A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Clinical trial NCT05020236 · RECRUITING
Trial details
- NCT number
- NCT05020236
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-04
- Primary completion
- 2026-02-26
- Enrollment
- 893
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.